Skip to content
Search

Latest Stories

Huxley Europe relaunches HuxQ10 Capsules with triple certification

Huxley Europe relaunches HuxQ10 Capsules with triple certification
The relaunch underscores Huxley Europe's commitment to health and welfare, offering specially developed formulas for users with dietary restrictions

"Barcodes are becoming obsolete, so we needed a unique selling point," comments Business Development Manager at Huxley Europe, Richard Wertheimer, celebrating the relaunch of its HuxQ10 capsules.

Now boasting a rare triple certification, HuxQ10 capsules are Halal approved by Halal Trust, Kosher approval by Rabbi Adler, and certification as vegan.


This milestone marks a significant step for the company, making HuxQ10 accessible to a wider audience.

Coenzyme Q10, or Q10, is a naturally occurring vitamin-like substance in the body, playing a crucial role in mitochondrial biogenetics and ATP production, which is vital for cellular energy.

It also acts as a powerful antioxidant, capable of regenerating alpha-tocopherol, the active form of vitamin E.

These properties help protect cells from oxidative damage, which is linked to aging and environmental stress.

Additionally, Q10 supports heart health and blood vessels, and enhances male fertility by improving sperm health and mobility.

HuxQ10 is derived from yeast fermentation, creating a product identical to the naturally occurring molecule.

The capsules are formulated with plant-based ingredients, ensuring they are free from the fourteen most common allergens, and contain no antimicrobial preservatives, gluten, wheat, or alcohol. This makes HuxQ10 suitable for a diverse range of dietary needs.

Dennis Gore, a community pharmacist at Dennis Gore Chemist, praised the product: "HuxQ10 is halal, kosher, and vegan certified, making it ideal for most customers."

The Q10 in HuxQ10 is dissolved in natural vegetable oil, with additional plant-based ingredients ensuring its stability and release within the body.

The proprietary SuperADME technology enhances the absorption and effectiveness of Q10, minimizing nutritional wastage.

Uniquely, HuxQ10's plant-based soft capsule shell is made from seaweed, ensuring ease of swallowing. The 100mg Q10 capsules simplify dosage adherence.

Huxley Europe has also embraced innovation with Buyerdock's on-pack iQRcodes, allowing consumers to access Vegan, Halal, and Kosher certificates, stockist information, and company details in various languages via their smartphones.

The relaunch underscores Huxley Europe's commitment to health and welfare, offering specially developed formulas for users with dietary restrictions.

HuxQ10 is priced at £11.95 for 30 capsules and £54.95 for 150 capsules, and is available through Thyme Marketing, Natural Dispensary, and Blukoo.

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Cat Smith MP Leads Call for Urgent Action

Health minister Wes Streeting

Pic credit: Getty Images

Urgent review into medicine shortages needed, ministers tell Streeting

Health minister Wes Streeting has been urged by 45 MPs to call an urgent review into medicine shortages that is impacting the health and safety of patients.

The news comes on the back of the death David Compton, a 44-year-old man who fell and suffered a heart attack which has been linked to him not being able to get medication for epilepsy.

Keep ReadingShow less